Answers are grounded in this paper and cite their sources.
There is an increasing interest in addressing the shortage of transplantable organs by using monetary payments to obtain them. Recent commentaries in the New York Times (1) and from the Kennedy Institute of Ethics Journal (2) share a recurring message: ‘it may be time to turn to a market approach’. The source of these commentaries has been from those who do not have a direct care responsibility for transplant patients or organ donors. Their primary focus has been to propose financial incentives for deceased donation; they have not recommended buying organs from live kidney donors.
No takes yet. Share an insight, caveat, or question.
Kahn et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: